A switch from GnRH agonist to GnRH antagonist in castration-resistant prostate cancer patients leads to a low response rate on PSA.
Masson-Lecomte A, Guy L, Pedron P, Bruyere F, Rouprêt M, Nsabimbona B, Dahan M, Hoffman P, Salomon L, Vordos D, Hoznek A, Le Corvoisier P, Morel P, Abbou C, de la Taille A.
Masson-Lecomte A, et al. Among authors: salomon l.
World J Urol. 2013 Apr;31(2):339-43. doi: 10.1007/s00345-012-0841-1. Epub 2012 Apr 15.
World J Urol. 2013.
PMID: 22527669